FindTrial
Sign In

A study on the use of Systemic Steroids and its combination with Remdesivir in Hospitalized COVID-19 patients

Effect of Systemic Steroids and its combination with Remdesivir in Hospitalized COVID-19 patients: A Retrospective Cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040400
Enrollment
908
Registered
2022-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals 18 or older with confirmed COVID-19 disease Patients on Systemic corticosteroids and its combination with Remdesivir

Exclusion criteria

Exclusion criteria: Patients tranferred to another facility without completion of treatment Patients over 90 years

Design outcomes

Primary

MeasureTime frame
Time to clinical improvement, In-hospital mortality, Time to death, Progression to mechanical VentilationTimepoint: February 2022 July 2022—

Secondary

MeasureTime frame
Change in Inflammatory Markers level , Adverse eventsTimepoint: February 2022 ,July 2022—

Countries

India

Contacts

Public ContactDr Sonal Sekhar M

Manipal College of Pharmaceutical Sciences

sonal.sekhar@manipal.edu7411338846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026